CD8A and neoplasm: Sensitivity analyses using MCP-counter and xCell revealed consistent patterns: high-risk samples exhibited increased tumor/plasma-cell signals alongside reduced B-lineage cells, CD8+ T cells, cytotoxic lymphocytes, and NK cells.